ITRM vs PEAK
Iterum Therapeutics PLC (ITRM) versus PEAK (PEAK) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
PEAK (PEAK) common stock.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
PEAK does not have a complete income-statement cache yet.
ITRM currently screens at market cap $38.6M.
Not investment advice. Open the ITRM and PEAK stock pages for the full models.
Not investment advice.